Cargando…
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
BACKGROUND: In hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia, progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is associated with significant morbidity and mortality. Severe dysregulated systemic inflammation is the putative mechanism...
Ejemplares similares
-
Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection
por: Confalonieri, Marco, et al.
Publicado: (2010) -
Limited role for bronchoalveolar lavage to exclude COVID-19 after negative upper respiratory tract swabs: a multicentre study
por: Geri, Pietro, et al.
Publicado: (2020) -
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
por: Salton, Francesco, et al.
Publicado: (2023) -
Isolation and Full-Length Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy
por: Licastro, Danilo, et al.
Publicado: (2020) -
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening
por: Larese Filon, Francesca, et al.
Publicado: (2021)